The clinical and paraclinical efficacy of tocilizumab in juvenile idiopathic arthritis

dc.contributor.author	Revenco, Ninel
dc.contributor.author	Cracea, Angela
dc.contributor.author	Mazur-Nicorici, Lucia
dc.contributor.author	Foca, Silvia
dc.contributor.author	Eremciuc, Rodica
dc.contributor.author	Gaidarji, Olga
dc.contributor.author	Iacomi, Vladimir
dc.contributor.author	Bogonovschi, Livia
dc.date.accessioned	2024-01-17T13:37:06Z
dc.date.available	2024-01-17T13:37:06Z
dc.date.issued	2021
dc.identifier.citation	REVENCO, Ninel, CRACEA, Angela, MAZUR-NICORICI, Lucia, et al. The clinical and paraclinical efficacy of tocilizumab in juvenile idiopathic arthritis. In: Archives of the Balkan Medical Union. 2021, nr. 2(56), pp. 185-192. ISSN 1584-9244.
dc.identifier.issn	1584-9244
dc.identifier.issn	2558-815X
dc.identifier.uri	https://umbalk.org/wp-content/uploads/2021/06/07.THE-CLINICAL-AND-PARACLINICAL-EFFICACY.pdf
dc.identifier.uri	https://doi.org/10.31688/ABMU.2021.56.2.07
dc.identifier.uri	http://repository.usmf.md/handle/20.500.12710/26740
dc.language.iso	en	en_US
dc.publisher	Balkan Medical Union	en_US
dc.relation.ispartof	Archives of the Balkan Medical Union	en_US
dc.subject	juvenile idiopathic arthritis	en_US
dc.subject	tocilizumab	en_US
dc.subject	inflammatory markers	en_US
dc.title	The clinical and paraclinical efficacy of tocilizumab in juvenile idiopathic arthritis	en_US
dc.title.alternative	L’efficacité clinique et paraclinique du tocilizumab dans l’arthrite juvénile idiopathique	en_US
dc.type	Article	en_US